KalVista Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is May - April.

Millions EUR. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 2, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2020 - 2016
Market Capitalization	714	603	448	264	296	505	Upgrade
Market Cap Growth	69.71%	34.74%	69.56%	-10.92%	-41.24%	183.52%	Upgrade
Enterprise Value	691	474	384	116	120	464	Upgrade
Last Close Price	13.80	11.70	10.00	7.65	11.96	20.60	Upgrade
PS Ratio	572.65	-	-	-	-	-	Upgrade
PB Ratio	20.02	7.18	2.32	1.81	1.69	2.36	Upgrade
P/TBV Ratio	20.02	7.18	2.32	1.81	1.69	2.36	Upgrade
EV/FCF Ratio	-4.71	-	-	-	-	-	Upgrade
Debt / Equity Ratio	3.40	1.18	0.04	0.05	0.04	0.02	Upgrade
Asset Turnover	0.01	-	-	-	-	-	Upgrade
Quick Ratio	5.16	5.22	9.70	11.18	15.81	26.67	Upgrade
Current Ratio	5.37	5.35	9.90	11.46	16.73	27.04	Upgrade
Return on Equity (ROE)	-190.18%	-121.50%	-68.90%	-53.69%	-37.23%	-27.13%	Upgrade
Return on Assets (ROA)	-60.98%	-48.34%	-41.94%	-35.80%	-25.38%	-19.86%	Upgrade
Return on Capital (ROIC)	-70.75%	-55.75%	-45.82%	-38.23%	-26.46%	-20.78%	Upgrade
Return on Capital Employed (ROCE)	-114.50%	-91.40%	-66.10%	-65.90%	-50.20%	-22.10%	Upgrade
Earnings Yield	-24.87%	-26.80%	-26.45%	-31.88%	-26.35%	-7.62%	Upgrade
FCF Yield	-20.56%	-22.40%	-18.64%	-26.23%	-25.31%	-4.98%	Upgrade
Buyback Yield / Dilution	-29.51%	-34.98%	-31.89%	-13.96%	-28.17%	-7.58%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.